A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969
This study is recruiting at 20 US sites in 12 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Major Depressive Disorder (MDD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Draig Therapeutics Ltd
- Last updated on ClinicalTrials.gov
- October 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arkansas · 2
- Draig Clinical Site · Bentonville, AR
- Draig Clinical Site · Little Rock, AR
California · 3
- Draig Clinical Site · Oceanside, CA
- Draig Clinical Site · San Diego, CA
- Draig Clinical Site · Torrance, CA
Florida · 2
- Draig Clinical Site · Miami, FL
- Draig Clinical Site · Orlando, FL
Georgia · 2
- Draig Clinical Site · Atlanta, GA
- Draig Clinical Site · Decatur, GA
Maryland · 1
- Draig Clinical Site · Gaithersburg, MD
Massachusetts · 1
- Draig Clinical Site · Watertown, MA
Mississippi · 1
- Draig Clinical Site · Flowood, MS
Nevada · 1
- Draig Clinical Site · Las Vegas, NV
New Jersey · 1
- Draig Clinical Site · Marlton, NJ
New York · 1
- Draig Clinical Site · New York, NY
Texas · 4
- Draig Clinical Site · Austin, TX
- Draig Clinical Site · Austin, TX
- Draig Clinical Site · DeSoto, TX
- Draig Clinical Site · Richardson, TX
Washington · 1
- Draig Clinical Site · Bellevue, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.